The prognosis after<unk>  is very good. Over the recent years, long-term success has improved and risks have decreased. One year after transplantation more than 95% of all patients are still alive and 80–85% of all<unk> es are still functional. After transplantation patients need lifelong immunosuppression. Immunosuppression increases the risk for a number of different kinds of infection and cancer. It is unclear if steroids, which are often used as immunosuppressant, can be replaced with something else.
Pancreas transplantation
Islet cell transplantation
Hepatoportoenterostomy
Liver transplantation
Pancreatectomy
Intestine transplantation
Enzyme replacement therapy
Percutaneous hepatic perfusion